Ulcerative colitis after SARS-CoV-2 infection

Kartsoli, Sofia; Vrakas, Spyridon; Kalomoiris, Dimitrios; Manoloudaki, Kassiani; Xourgias, V

doi:10.4322/acr.2021.378

Cited by 4 publications

(1 citation statement)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the exact relationship between UC and COVID-19 is not known and there are very few publications, in this scarce amount of literature it has been stated that microbiota disorders and local immune deregulation mechanisms can be the culprit to induce chronic colonic inflammation after an COVID-19 infection. (6) It has been postulated that the worsening of UC symptoms following a COVID-19 infection could be associated with the initiation of mimicking the molecular autoimmunity caused by viral infections, specifically by COVID-19. This leads to the activation of immune responses targeting antigenic epitopes, known as epitope spread, distinct from those implicated in the disease process.…”

Section: Discussionmentioning

confidence: 99%

Recurrent bloody diarrhea in an adult male COVID-19 patient – A Case report

Tural,

Gönenç

2023

tjtfp

View full text Add to dashboard Cite

Ulcerative colitis is an inflammatory bowel disease presenting with symptoms such as abdominal pain, bloody diarrhea and weight loss. Following courses like COVID-19 infection, respiratory diseases, surgical operations, etc., the duration and severity of symptoms may increase. Although the exact relationship between exacerbation of ulcerative colitis and COVID-19 is not fully understood, and there is scarce literature demonstrating that factors such as local immune deregulation, psychological stress, and the initiation of autoimmunity may play a role. In this case report, we aimed to present a patient with ulcerative colitis complaining of recurrent bloody diarrhea, tenesmus, and abdominal pain after COVID-19 infection.

show abstract

Section: Discussionmentioning

confidence: 99%

Recurrent bloody diarrhea in an adult male COVID-19 patient – A Case report

Tural,

Gönenç

2023

tjtfp

View full text Add to dashboard Cite

show abstract

The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts

Atia,

Bryder,

Mendelovici

et al. 2024

Journal of Crohn's and Colitis

View full text Add to dashboard Cite

Background We aimed to explore the epidemiology of inflammatory bowel diseases (IBD) in association with the COVID-19 pandemic in two countries with different lockdown policies. Methods We utilized nationwide IBD cohorts in Israel and Sweden to explore the incidence of IBD during the pandemic compared to three years prior (2017- 2019). We examined temporal trends through the presence of inflection points by Joinpoint regression analysis and reported average monthly percentage changes (AMPC). Results A total of 155,837 patients with IBD were included (Israel, 58,640; Sweden, 97,197). The annual incidence of IBD was stable until 2019 in both countries and since, it decreased in Israel (AAPC of -16.6% [95%CI -19.9% to -10.0%]) and remained stable in Sweden (AAPC of -3.5% [95%CI -11.6% to 3.7%]). When exploring the monthly incidence during the pandemic, in Israel the rate remained stable until November 2020 (AMPC 2.3% [95%CI -13.4% to 29.9%]) and then decreased sharply (AMPC -6.4% [95%CI-20.8% to 17.0%]) until February 2021 and -20.1% [95%CI -38.9% to -4.7%]) from February 2021), while in Sweden, which had a less stringent lockdown policy, it decreased slightly until July 2020 (AMPC -3.3% [95%CI -21.6% to 20.3%]), but increased thereafter (AMPC 13.6% [95%CI -12.6% to 27.0%]). The change of incidence rate in Sweden occurred mainly in elderly-onset patients, the only population with significant restrictions during the pandemic. Conclusion The incidence of IBD decreased during the pandemic in association with lockdowns, more so in Israel, which had more stringent policies. Future studies are needed to determine the long-term effect of the pandemic on IBD.

show abstract

Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19

Mounsif¹,

Setouani²,

Nadi³

et al. 2022

Cureus

View full text Add to dashboard Cite

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) whose management depends on its severity, localization, and course. The coronavirus disease 2019 (COVID-19) pandemic has made the management of this disease more difficult, as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) routinely causes respiratory infection, but can also target the gastrointestinal tract. Multiple cases of de novo IBD, IBD flare-ups, and colitis have been associated with COVID-19 infection. We present the case of two patients, with a history of UC, who presented respectively a mild and a severe flare-up of their disease associated with COVID-19 infection.Regardless of recommendations, we decided to optimize the patient's treatment and obtained good clinical, biological, and endoscopic results. This report on the two cases suggests that remaining cautious and optimizing can be a good therapeutic alternative for these patients rather than modifying the treatment.

show abstract

Ulcerative colitis after SARS-CoV-2 infection

Cited by 4 publications

References 23 publications

Recurrent bloody diarrhea in an adult male COVID-19 patient – A Case report

Recurrent bloody diarrhea in an adult male COVID-19 patient – A Case report

The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide Cohorts

Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19

Contact Info

Product

Resources

About